First trimester ultrasonography in screening and detection of fetal anomalies

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 145, Issue 1, 2007, Pages 45-61

  Sonek, Jiri ^a,b,c  

^a WRIGHT STATE UNIVERSITY   (United States)

^b MIAMI VALLEY HOSPITAL   (United States)

^c Fetal Medicine Foundation   (United States)

Author keywords

Fetal anomalies; Fetal markers; First trimester obstetrical ultrasound

Indexed keywords

COLLAGEN TYPE 4; LAMININ; SUPEROXIDE DISMUTASE;

ANEUPLOIDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FETUS; FETUS ECHOGRAPHY; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATIONAL AGE; HUMAN; PATIENT COUNSELING; PERINATAL MORBIDITY; PERINATAL MORTALITY; PRIORITY JOURNAL; REVIEW; TRANSVAGINAL ECHOGRAPHY;

ANEUPLOIDY; BIOLOGICAL MARKERS; FEMALE; FETUS; HUMANS; NUCHAL TRANSLUCENCY MEASUREMENT; PREGNANCY; PREGNANCY TRIMESTER, FIRST; ULTRASONOGRAPHY, DOPPLER; ULTRASONOGRAPHY, PRENATAL;

EID: 33947278981     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.30120     Document Type: Review

References (231)

1. Achiron R, Rotstein Z, Lipitz S, Mashiach S, Hegesh J. 1994. First-trimester diagnosis of fetal congenital heart disease by transvaginal ultrasonography. Obstet Gynecol 84:69-72.
2. Achiron R, Heggesh J, Grisaru D, Goldman B, Lipitz S, Yagel S, Frydman M. 2000. Noonan syndrome: A cryptic condition in early gestation. Am J Med Genet 92:159-165.
3. Adekunle O, Gopee A, El-Sayed M, Thilaganathan B. 1999. Increased first-trimester nuchal translucency: Pregnancy and infant outcomes after routine screening for Down's syndrome in an unselected antenatal population. Br J Radiol 72:457-460.
4. Aliakbar S, Brown PR, Bidwell D, Nicolaides KH. 1993. Human erythrocyte superoxide dismutase in adults, neonates, and normal, hypoxaemic, anaemic, and chromosomally abnormal fetuses. Clin Biochem 26:109-115.
5. Antolin E, Comas C, Torrents M, Munoz A, Figueras F, Echevarria M, Cararach M, Carrera JM. 2001. The role of ductus venosus blood flow assessment in screening for chromosomal abnormalities at 10-16 weeks of gestation. Ultrasound Obstet Gynecol 17:295-300.
6. Azar G, Snijders RJM, Gosden CM, Nicolaides KH. 1991. Fetal nuchal cystic hygromata: Associated malformations and chromosomal defects. Fetal Diagn Ther 6:46-57.
7. Babcook CJ, Chong BW, Salamat MS, Ellis WG, Goldstein RB. 1996. Sonographic anatomy of the developing cerebellum: Normal embryology can resemble pathology. AJR Am J Roentgol 166:427-433.
8. Bahado-Singh RO, Lynch L, Deren O, Morotti R, Copel J, Mahoney MJ, Williams J. 1997. First-trimester growth restriction and fetal aneuploidy: The effect of type of aneuploidy and gestational age. Am J Obstet Gynecol 176:976-980.
9. Bahado-Singh RO, Wapner R, Thom E, Zachary J, Platt L, Mahoney MJ, Johnson A, Silver RK, Pergament E, Filkins K, Hogge WA, Wilson RD, Jackson LG. 2005. Elevated first-trimester nuchal translucency increases the risk of congenital heart defects. Am J Obstet Gynecol 192:1357-1361.
10. Ben Ami M, Perlitz Y, Haddad S, Matilsky M. 1997. Increased nuchal translucency is associated with asphyxiating thoracic dysplasia. Ultrasound Obstet Gynecol 10:297-298.
11. Benacerraf BR, Gelman R, Frigoletto FD. 1987. Sonographic identification of second trimester fetuses with Down's syndrome. N Engl J Med 317:1371-1376.
12. Bilardo CM, Pajkrt E, de Graaf IM, Mol BWJ, Bleker OP. 1998. Outcome of fetuses with enlarged nuchal translucency and normal karyotype. Ultrasound Obstet Gynecol 11:401-406.
13. Bilardo CM, Muller MA, Zikulnig L, Schipper M, Hecher K. 2001. Ductus venosus studies in fetuses at high risk for chromosomal or heart abnormalities: Relationship with nuchal translucency measurement and fetal outcome. Ultrasound Obstet Gynecol 17:288-294.
14. Bindra R, Curcio P, Cicero S, Martin A, Nicolaides KH. 2001. Uterine artery Doppler at 11-14 weeks of gestation in chromosomally abnormal fetuses. Ultrasound Obstet Gynecol 18:587-589.
15. Bohlandt S, von Kaisenberg CS, Wewetzer K, Christ B, Nicolaides KH, Brand-Saberi B. 2000. Hyaluronan in the nuchal skin of chromosomally abnormal fetuses. Hum Reprod 15:1155-1158.
16. Borrell A, Martinez JM, Farre T, Azulay M, Cararach V, Fortuny A. 2001. Reversed end-diastolic flow in first trimester umbilical artery: An ominous new sign for fetal outcome. Am J Obstet Gynecol 185:204-207.
17. Borrell A, Martinez JM, Seres A, Borobio V, Cararach V, Fortuny A. 2003. Ductus venosus assessment at the time of nuchal translucency measurement in the detection of fetal aneuploidy. Prenat Diagn 23:921-926.
18. Brady AF, Pandya PP, Yuksel B, Greenough A, Patton MA, Nicolaides KH. 1998. Outcome of chromosomally normal livebirths with increased fetal nuchal translucency at 10-14 weeks' gestation. J Med Genet 35:222-224.
19. Braithwaite JM, Armstrong MA, Economides DL. 1996. Assessment of fetal anatomy at 12 to 13 weeks of gestation by transabdominal and transvaginal sonography. Br J Obstet Gynaecol 103:82-85.
20. Bromley B, Benacerraf B. 1995. Using the number of yolk sacs to determine amnionicity in early first trimester monochorionic twins. J Ultrasound Med 14:415-419.
21. Bronshtein M, Zimmer EZ. 1991. Transvaginal sonographic follow-up on the formation of fetal cephalocele at 13-19 weeks' gestation. Obstet Gyncol 78:528-530.
22. Bronshtein M, Yoffe N, Brandes JM, Blumenfeld Z. 1990. First and early second-trimester diagnosis of fetal urinary tract anomalies using transvaginal sonography. Prenat Diag 10:653-666.
23. Bronshtein M, Bar-Hava I, Blumenfeld Z. 1992. Clues and pitfalls in the early prenatal diagnosis of "late onset" infantile polycystic kidney. Prenatal Diagn 12:293-298.
24. Bronshtein M, Amit A, Achiron R, Noy I, Blumenfeld Z. 1994. The early prenatal songraphic diagnosis of renal agenesis: Techniques and possible pitfalls. Prenat Diagn 14:291-297.
25. Brown R, Di Luzio L, Gomes C, Nicolaides KH. 1998. The umbilical artery pulsatility index in the first trimester: Is there an association with increased nuchal translucency or chromosomal abnormality? Ultrasound Obstet Gynecol 12:244-247.
26. Brown RN, Di Luzio L, Gomes C, Nicolaides KH. 1999. First trimester umbilical venous Doppler sonography in chromosomally normal and abnormal fetuses. J Ultrasound Med 18:543-546.
27. Bulas D, Saal H, Allen JF, Kapur S, Nies BM, Newman K. 1992. Cystic hygroma and congenital diaphragmatic hernia: Early prenatal sonographic evaluation of Fryn's syndrome. Prenat Diagn 12:867-875.
28. Carvalho JS, Moscoso G, Ville Y. 1998. First trimester transabdominal fetal echocardiography. Lancet 351:1023-1027.
29. Cha'Ban FK, van Splunder P, Los FJ, Wladimiroff JW. 1996. Fetal outcome in nuchal translucency with emphasis on normal fetal karyotype. Prenat Diagn 16:537-541.
30. Cheng C, Bahado-Singh RO, Chen S, Tsai M. 2004. Pregnancy outcomes with increased nuchal translucency after routine Down syndrome screening. Int J Gynaecol Obstet 84:5-9.
31. Chervenak FA, Isaacson G, Blakemore KJ, Breg RW, Hobbins JC, Berkowitz RL, Tartora M, Mayden K, Mahoney MJ. 1983. Fetal cystic hygroma: Cause and natural history. New Engl J Med 309:822-825.
32. Christiaens GCML, de Pater JM, Stoutenbeek P, Drogtrop A, Wanders RJA, Beemer FA. 2000. First trimester nuchal anomalies as a prenatal sign of Zellweger syndrome. Prenat Diagn 20:517-525.
33. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides KH. 2001. Absence of nasal bone in fetuses with Trisomy 21 at 11-14 weeks of gestation: An observational study. Lancet 358:1665-1667.
34. Cicero S, Bindra R, Rembouskos G, Spencer K, Nicolaides KH. 2003a. Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free beta-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn 23:306-310.
35. Cicero S, Dezerega V, Andrade E, Scheier M, Nicolaides KH. 2003b. Learning curve for sonographic examination of the fetal nasal bone at 11-14 weeks. Ultrasound Obstet Gynecol 22:135-137.
36. Cicero S, Longo D, Rembouskos G, Sacchini C, Nicolaides KH. 2003c. Absent nasal bone at 11-14 weeks of gestation and chromosomal defects. Ultrasound Obstet Gynecol 22:31-35.
37. Cicero S, Curcio P, Rembouskos G, Sonek J, Nicolaides KH. 2004a. Maxillary length at 11-14 weeks of gestation in fetuses with Trisomy 21. Ultrasound Obstet Gynecol 24:19-22.
38. Cicero S, Rembouskos G, Vandecruys H, Hogg M, Nicolaides KH. 2004b. Likelihood ratio for Trisomy 21 in fetuses with absent nasal bone at the 11-14 weeks scan. Ultrasound Obstet Gynecol 23:218-223.
39. Cicero S, Avgidou K, Rembouskos G, Kagan KO, Nicolaides KH. 2006. Nasal bone in first-trimester screening for trisomy 21. Am J Obstet Gynecol 195:109-114.
40. Clementschitsch G, Hasenohrl G, Steiner H, Staudach A. 2003. Early diagnosis of a fetal skeletal dysplasia associated with increased nuchal translucency with 2D and 3D ultrasound. Ultraschall Med 24:349-352.
41. Comstock CH, Malone FD, Ball RH, Nyberg DA, Saade GR, Berkowitz RL, Ferreira J, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Bianchi DW, D'Alton ME, FASTER Research Consortium. 2006. Is there a nuchal translucency millimeter measurement above which there is no added benefit from first trimester serum screening? Am J Obstet Gynecol 195:843-847.
42. Cuckle H, Benn P, Wright D. 2005. Down syndrome screening in the first and/or second trimester: Model predicted performance using meta-analysis parameters. Semin Perinatol 29:252-257.
43. Cullen MT, Gabrielli S, Green JJ, Rizzo N, Mahoney MJ, Salafia C, Bovicelli L, Hobbins JC. 1990a. Diagnosis and significance of cystic hygroma in the first trimester. Prenat Diagn 10:643-651.
44. Cullen MT, Green J, Whetham J, Salafia C, Gabrielli S, Hobbins JC. 1990b. Transvaginal detection of congenital anomalies in the first trimester. Am J Obstet Gynecol 163: 466-476.
45. Daskalakis G, Sebire NJ, Jurkovic D, Snijders RJM, Nicolaides KH. 1997. Body stalk anomaly at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 10:416-418.
46. De Biasio P, Venturini PL. 2002. Absence of nasal bone and detection of trisomy 21. Lancet 13:1344.
47. de Graaf IM, Pajkrt E, Keessen M, Leschot NJ, Bilardo CM. 1999. Enlarged nuchal translucency and low serum protein concentration as possible markers for Zellweger syndrome. Ultrasound Obstet Gynecol 13: 268-270.
48. de Graaf IM, Tijmstra T, Bleker OP, van Lith JM. 2002. Womens' preference in Down syndrome screening. Prenat Diagn 22:624-629.
49. de Jong-Pleij EA, Stoutenbecek P, van der Mark-Batseva NN, Muller MA, Ribbert L. 2002. The association of spinal muscular atrophy type II and increased nuchal translucency. Ultrasound Obstet Gynecol 19:312-313.
50. den Hollander NS, van der Harten HJ, Vermeij-Keers C, Niermeijer MF, Wladimiroff JW. 1997. First trimester diagnosis of Blomstrand lethal osteochondrodysplasia. Am J Med Genet 73:345-350.
51. Down L. 1866. Observations on an ethnic classification of idiots. Clin Lect Rep, London Hospital 3:259-262.
52. Drugan A, Johnson MP, Isada NB, Holzgreve W, Zador IE, Dombrowski MP, Sokol RJ, Hallak M, Evans MI. 1992. The smaller than expected first-trimester fetus is at increased risk for chromosome anomalies. Am J Obstet Gynecol 167:1525-1528.
53. Economides DL, Braithwaite JM. 1998. First trimester ultrasonographic diagnosis of fetal structural abnormalities in a low risk population. Br J Obstet Gynaecol 105: 53-57.
54. Eliyahu S, Weiner E, Lahav D, Shalev E. 1997. Early sonographic diagnosis of Jarcho-Levin syndrome: A prospective screening program in one family. Ultrasound Obstet Gynecol 9:314-318.
55. Faiola S, Tsoi E, Huggon IC, Allan LD, Nicolaides KH. 2005. Likelihood ratio for trisomy 21 in fetuses with tricuspid regurgitation at the 11 to 13+6 week scan. Ultrasound Obstet Gynecol 26:22-27.
56. Falcon O, Auer M, Gerovassili A, Spencer K, Nicolaides KH. 2006. Screening for trisomy 21 by tricuspid regurgitation, nuchal translucency and maternal serum free β-hCG and PAPP-A at 11+0 to 13+6 weeks. Ultrasound Obstet Gynecol 27:151-155.
57. Farkas LG, Katic MJ, Forrest CR, Litsas L. 2001. Surface anatomy of the face in Down's syndrome: Linear and angular measurements in the craniofacial regions. J Craniofac Surg 12:373-379.
58. Favre R, Kohler M, Gasser B, Muller F, Nisand I. 1999. Early fetal megacystis between 11 and 15 weeks of gestation. Ultrasound Obstet Gynecol 14:402-406.
59. Fincham J, Pandya PP, Yuksel B, Loong YM, Shah J. 2002. Increased first-trimester nuchal translucency as a prenatal manifestation of salt-wasting congenital adrenal hyperplasia. Ultrasound Obstet Gynecol 20:392-394.
60. Fisk NM, Vaughan J, Smidt M, Wigglesworth J. 1991. Transvaginal ultrasound recognition of nuchal oedema in the first-trimester diagnosis of achondrogenesis. J Clin Ultrasound 19:586-590.
61. Flores Anton B, Bonet Serra B, Adiego Burgos B, Martinez Orgado J, Martin Ancel A, Perez-Lescure Picarzo J. 2003. Congenital adrenal hyperplasia: An association with increased fetal nuchal translucency. An Pediatr (Barc) 58:52-54.
62. Fukada Y, Yasumizu T, Takizawa M, Amemiya A, Hoshi K. 1998. The prognosis of fetuses with transient nuchal translucency in the first and early second trimester. Acta Obstet Gynecol Scand 76:913-916.
63. Fukada Y, Amemiya A, Kohno K, Sunami R, Kobayashi Y, Hoshi K. 2002. Prenatal course and pregnancy outcome of fetuses with a transient nuchal translucency. Int J Gynaecol Obstet 79:225-228.
64. Galindo A, Comas C, Martinez JM, Gutierrez-Larraya F, Carrera JM, Puerto B, Borrell A, Mortera C, De la Fuente R. 2003. Cardiac defects in chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks of gestation. J Mater Fetal Neonatal Med 13:163-170.
65. Gembruch U, Knopfle G, Bald R, Hansmann M. 1993. Early diagnosis of fetal congenital heart disease by transvaginal echocardiography. Ultrasound Obstet Gynecol 3:310-317.
66. Ghi T, Huggon IC, Zosmer N, Nicolaides KH. 2001. Incidence of major structural cardiac defects associated with increased nuchal translucency but normal karyotype. Ultrasound Obstet Gynecol 18:610-614.
67. Goldstein RB, Filly RA, Callen PW. 1989. Sonography of anencephaly: Pitfalls in early diagnosis. J Clin Ultrasound 17:397-402.
68. Green JJ, Hobbins JC. 1988. Abdominal ultrasound examination of the first trimester fetus. Am J Obstet Gynecol 159:165-175.
69. Guzman ER. 1990. Early prenatal diagnosis of gastroschisis with transvaginal sonography. Am J Obstet Gynecol 162:1253-1254.
70. Hafner E, Schuchter K, Liebhart E, Philipp K. 1998. Results of routine fetal nuchal translucency measurement at weeks 10-13 in 4,233 unselected pregnant women. Prenat Diagn 18:29-34.
71. Hafner E, Schuller T, Metzenbauer M, Schuchter K, Philipp K. 2003. Increased nuchal translucency and congenital heart defects in a low-risk population. Prenat Diagn 23:985-989.
72. Hecher K, Campbell S, Doyle P, Harrington K, Nicolaides KH. 1995. Assessment of fetal compromise by Doppler ultrasound investigation of the fetal circulation. Arterial, intracardiac, and venous blood flow velocity studies. Circulation 91:129-138.
73. Hernadi L, Torocsik M. 1997. Screening for fetal anomalies in the 12th week of pregnancy by transvaginal sonography in an unselected population. Prenat Diagn 17:753-759.
74. Hewitt B. 1993. Nuchal translucency in the first trimester. Aust NZ J Obstet Gynaecol 33: 389-391.
75. Hewitt BG, de Crespigny L, Sampson AJ, Ngu ACC, Shekleton P, Robinson HP. 1996. Correlation between nuchal thickness and abnormal karyotype in first trimester fetuses. MJA 165:365-368.
76. Hiippala A, Eronen M, Taipale P, Salonen R, Hiilesmaa V 2001. Fetal nuchal translucency and normal chromosomes: A long-term follow-up study. Ultrasound Obstet Gynecol 18:18-22.
77. Hill LM, Leary J. 1998. Transvaginal sonographic diagnosis of short-rib polydactyly dysplasia at 13 weeks' gestation. Prenat Diagn 18: 1198-1201.
78. Hobbins JC, Jones OW, Gottesfeld S, Persutte W. 1994. Transvaginal sonography and transabdominal embryoscopy in the first-trimester diagnosis of Smith-Lemli-Opitz syndrome, type 2. Am J Obstet Gynecol 171:546-549.
79. Huggon IC, DeFigueiredo DB, Allan LD. 2003. Tricuspid regurgitation in the diagnosis of chromosomal anomalies in the fetus at 11-14 weeks of gestation. Heart 89:1071-1073.
80. Hull AD, James G, Pretorius DH. 2001. Detection of Jarcho-Levin syndrome at 12 weeks' gestation by nuchal translucency screening and three-dimensional ultrasound. Prenat Diagn 21:390-394.
81. Hyett JA, Clayton PT, Moscoso G, Nicolaides KH. 1995. Increased first trimester nuchal translucency as a prenatal manifestation of Smith-Lemli-Opitz syndrome. Am J Med Genet 58:374-376.
82. Hyett J, Moscoso G, Papapanagiotou G, Perdu M, Nicolaides KH. 1996a. Abnormalities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation. Ultrasound Obstet Gynecol 7:245-250.
83. Hyett JA, Brizot ML, von Kaisenberg CS, McKie AT, Farzaneh F, Nicolaides KH. 1996b. Cardiac gene expression of atrial natriuretic peptide and brain natriuretic peptide in trisomic fetuses. Obstet Gynecol 87:506-510.
84. Hyett J, Noble P, Sebire NJ, Snijders RJM, Nicolaides KH. 1997a. Lethal congenital arthrogryposis presents with increased nuchal translucency at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 9:310-313.
85. Hyett JA, Perdu M, Sharland GK, Snijders RSM, Nicolaides KH. 1997b. Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects. Ultrasound Obstet Gynecol 10:242-246.
86. Hyett J, Perdu M, Sharland G, Snijders R, Nicolaides KH. 1999. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: Population based cohort study. Br Med J 318:81-85.
87. Jauniaux E, Gavrill P, Khun P, Kurdi W, Hyett J, Nicolaides KH. 1996. Fetal heart rate and umbilico-placental Doppler flow velocity waveforms in early pregnancies with a chromosomal abnormality and/or an increased nuchal translucency thickness. Hum Reprod 11:435-439.
88. Jauniaux E, Brown R, Snijders RJ, Noble P, Nicolaides KH. 1997. Early prenatal diagnosis of triploidy. Am J Obstet Gynecol 176:550-554.
89. Johnson A, Losure TA, Weiner S. 1985. Early diagnosis of anencephaly. J Clin Ultrasound 12:503-505.
90. Johnson P, Sharland G, Maxwell D, Allan L. 1992. The role of transvaginal sonography in the early detection of congenital heart disease. Ultrasound Obstet Gynecol 2: 248-251.
91. Johnson MP, Johnson A, Holzgreve W, Isada NB, Wapner RJ, Treadwell MC, Heeger S, Evans M. 1993. First-trimester simple hygroma: Cause and outcome. Am J Obstet Gynecol 168:156-161.
92. Johnson SP, Sebire NJ, Snijders RJM, Tunkel S, Nicolaides KH. 1997. Ultrasound screening for anencephaly at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 9: 14-16.
93. Johnson JM, Babul-Hirji R, Chitayat D. 2001. First-trimester increased nuchal translucency and fetal hypokinesia associated with Zellweger syndrome. Ultrasound Obstet Gynecol 17:344-346.
94. Josefsson A, Molander E, Selbing A. 1998. Nuchal translucency as a screening test for chromosomal abnormalities in a routine first trimester ultrasound examination. Acta Obstet Gynecol Scand 77:497-499.
95. Kanellopoulos V, Katsetos C, Economides DL. 2003. Examination of fetal nasal bone and repeatability of measurement in early pregnancy. Ultrasound Obstet Gynecol 22:131-134.
96. Keeling JW, Hansen BF, Kjaer I. 1997. Pattern of malformation in the axial skeleton in human trisomy 21 fetuses. Am J Med Genet 68: 466-471.
97. Kennedy KA, Flick KJ, Thurmond AS. 1990. First-trimester diagnosis of exencephaly. Am J Obstet Gynecol 162:461-463.
98. Kiserud T, Eik-Nes SH, Blaas HG, Hellevik LR, Simensen B. 1994. Ductus venosus blood velocity and the umbilical circulation in the seriously growth-retarded fetus. Ultrasound Obstet Gynecol 4:109-114.
99. Kuhn P, Brizot ML, Pandya PP, Snijders RJ, Nicolaides KH. 1995. Crown-rump length in chromosomally abnormal fetuses at 10 to 13 weeks' gestation. Am J Obstet Gynecol 172:32-35.
100. Kushnir O, Izquierdo L, Vigil D, Curet LB. 1990. Early transvaginal diagnosis of gastroschisis. J Clin Ultrasound 18:194-197.
101. Lam YH, Eik-Nes SH, Tang MHY, Lee CP, Nicholls JM. 1999a. Prenatal sonographic features of spondylocostal dysostosis and diaphragmatic hernia in the first trimester. Ultrasound Obstet Gynecol 13: 213-215.
102. Lam YH, Tang MH, Lee CP, Tse HY. 1999b. Nuchal translucency in fetuses affected by homozygous α-thalassemia-1 at 12-13 weeks of gestation. Ultrasound Obstet Gynecol 13:238-240.
103. Larose C, Massoc P, Hillion Y, Bernard JP, Ville Y. 2003. Comparison of fetal nasal bone assessment by ultrasound at 11-14 weeks and by postmortem X-ray in trisomy 21 fetuses: A prospective observational study. Ultrasound Obstet Gynecol 22:27-30.
104. Liao AW, Snijders R, Geerts L, Spencer K, Nicolaides KH. 2000. Fetal heart rate in chromosomally abnormal fetuses. Ultrasound Obstet Gynecol 16:610-613.
105. Liao AW, Sebire NJ, Geerts L, Cicero S, Nicolaides KH. 2003. Megacystis at 10-14 weeks of gestation: Chromosomal defects and outcome according to bladder length. Ultrasound Obstet Gynecol 21:338-341.
106. Lin Y, Chang F, Liu C. 1992. Antenatal detection of hydranencephaly at 12 weeks menstrual age. J Clin Ultrasound 20:62-64.
107. Longo D, DeFigueiredo D, Cicero S, Sacchini C, Nicolaides KH. 2004. Femur and humerus length in Trisomy 21 fetuses at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 23:143-147.
108. Lopes LM, Brizot ML, Lopes MA, Ayello VD, Schultz R, Zugaib M. 2003. Structural and functional cardiac abnormalities identified prior to 16 weeks' gestation in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 22:470-478.
109. Makrydimas G, Souka A, Skentou H, Lolis D, Nicolaides K. 2001. Osteogenesis imperfecta and other skeletal dysplasias presenting with increased nuchal translucency in the first trimester. Am J Med Genet 98:117-120.
110. Makrydimas G, Sotiriadis A, Ioannidis JP. 2003. Screening performance of first-trimester nuchal translucency for major cardiac defects: A meta-analysis. Am J Obstet Gynecol 189:1330-1335.
111. Makrydimas G, Sotiradis A, Huggon IC, Simpson J, Sharland G, Carvlho JS, Daubeney PE, Ioannidis JPA. 2005. Nuchal translucency and fetal cardiac defects: A pooled analysis of major fetal echocardiography centers. Am J Obstet Gynecol 192:89-95.
112. Malone FD, Ball RH, Nyberg DA, Comstock CH, Saade G, Berkowitz RL, Dugoff L, Craigo SD, Carr SR, Wolfe HM, Tripp T, D'Alton ME, FASTER Research Consortium. 2004. First trimester nasal bone evaluation for aneuploidy in the general population. Obstet Gynecol 104:1222-1228.
113. Malone FD, Ball RH, Nyberg DA, Comstock CH, Saade GR, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Canick JA, Bianchi DW, D'Alton ME, FASTER Trial Consortium. 2005. First trimester septated cystic hygroma: Prevalence, natural history, and pediatric outcome. Obstet Gynecol 106:288-294.
114. Mangione R, Guyon F, Taine L, Wen ZQ, Roux D, Vergnaud A, Maugey-Laulom B, Horovitz J, Saura R. 2001. Pregnancy outcome and prognosis in fetuses with increased first-trimester nuchal translucency. Fetal Diagn Ther 16:360-363.
115. Markenson G, Correia LA, Cohn G, Bayer L, Kanaan C. 2000. Parvoviral infection associated with increased nuchal translucency: A case report. J Perinatol 20:129-131.
116. Martinez JM, Borrell A, Antonin E, Puerto B, Casals E, Ojuel J, Fortuny A. 1997. Combining nuchal translucency and umbilical Doppler velocimetry for detecting fetal trisomies in the first trimester of pregnancy. Br J Obstet Gynaecol 104:11-14.
117. Martinez JM, Echevarria M, Gomez O, Del Rio M, Borrell A, Puerto B, Fortuny A. 2003. Jugular vein and carotid artery blood flow in fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 22:464-469.
118. Masturzo B, Hyett JA, Kalache KD, Rumsby G, Jauniaux E, Rodeck CH. 2001. Increased nuchal translucency as a prenatal manifestation of congenital adrenal hyperplasia. Prenat Diagn 21:314-316.
119. Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH. 1998. Screening for chromosomal abnormalities at 11-14 weeks: The role of ductus venosus blood flow. Ultrasound Obstet Gynecol 2:380-384.
120. Matias A, Huggon I, Areias JC, Montenegro N, Nicolaides KH. 1999. Cardiac defects in chromosomally normal fetuses with abnormal ductus venosus blood flow at 10-14 weeks. Ultrasound Obstet Gynecol 14:307-310.
121. Mavrides E, Cobian-Sanchez F, Tekay A, Moscoso G, Campbell S, Thilaganathan B, Carvalho JS. 2001. Limitations of using first trimester nuchal translucency measurement in routine screening for major congenital heart defects. Ultrasound Obstet Gynecol 17:106-110.
122. Mavrides E, Sairam S, Hollis B, Thilaganathan B. 2002. Screening for aneuploidy in the first trimester by assessment of blood flow in the ductus venosus. BJOG 109:1015-1019.
123. Maymon R, Dreazen E, Tovbin Y, Bukovsky I, Weinraub Z, Herman A. 1999. The feasibility of nuchal translucency measurement in higher order multiple gestations achieved by assisted reproduction. Hum Reprod 14:2102-2105.
124. Maymon R, Jauniaux E, Cohen O, Dreazen E, Weinraub Z, Herman A. 2000. Pregnancy outcome and infant follow-up of fetuses with abnormally increased first trimester nuchal translucency. Hum Reprod 15: 2023-2027.
125. McAuliffe F, Winsor S, Hornberger L, Johnson JA. 2003. Fetal cardiac defects and increased nuchal translucency thickness. Am J Obstet Gynecol 189: Abstract 571.
126. Meizner I, Barnhard Y. 1995. Achondrogenesis type I diagnosed by transvaginal ultrasonography at 13 weeks' gestation. Am J Obstet Gynecol 173:1620-1622.
127. Michailidis GD, Economides DL. 2001. Nuchal translucency measurement and pregnancy outcome in karyotypically normal fetuses. Ultrasound Obstet Gynecol 17:102-105.
128. Minderer S, Gloning KP, Henrich W, Stoger H. 2003. The nasal bone in fetuses with trisomy 21: Sonographic versus pathomorphological findings. Ultrasound Obstet Gynecol 22: 16-21.
129. Molina F, Avgidou K, Kagan K, Poggi S, Nicolaides K. 2006. Cystic hygromas, nuchal edema, and nuchal translucency at 11-14 weeks of gestation. Obstet Gynecol 107:678-683.
130. Monteagudo A, Timor-Tritsch I, Sharma S. 1994. Early and simple determination of chorionic and amniotic type in multifetal gestations in the first 14 weeks by high frequency transvaginal ultrasound. Am J Obstet Gynecol 170:824-829.
131. Monteagudo A, Mayberry P, Rebarber A, Paidas M, Timor-Tritsch IE. 2002. Sirenomelia sequence: First-trimester diagnosis with both two- and three-dimensional sonography. Ultrasound Med 21:915-920.
132. Moselhi M, Thilaganathan B. 1996. Nuchal translucency: A marker for the antenatal diagnosis of aortic coarctation. Br J Obstet Gynaecol 103:1044-1045.
133. Mulvey S, Wallace EM. 2000. Women's knowledge of and attitudes to first and second trimester screening for Down's syndrome. Br J Obstet Gynaecol 107:1302-1305.
134. Mulvey S, Baker L, Edwards A, Oldham J, Shekleton P, Wallace EM. 2002, Optimising the timing for nuchal translucency measurement. Prenat Diagn 22:775-777.
135. Murta CG, Moron AF, Avila MA, Weiner CP. 2002. Application of ductus venosus Doppler velocimetry for the detection of fetal aneuploidy in the first trimester of pregnancy. Fetal Diagn Ther 1:308-314.
136. Nadel A, Bromley B, Benacerraf BR. 1993. Nuchal thickening or cystic hygromas in first- and early second-trimester fetuses: Prognosis and outcome. Obstet Gynecol 82:43-48.
137. Nicolaides KH, Rodeck CH, Lange I, Watson J, Gosden CM, Millar D, Mibashan RS, Moniz C, Morgan-Capner P, Campbell S. 1985a. Fetoscopy in the assessment of unexplained fetal hydrops. Br J Obstet Gynaecol 92:671-679.
138. Nicolaides KH, Warenski JC, Rodeck CH. 1985b. The relationship of fetal plasma protein concentration and hemoglobin level to the development of hydrops in rhesus isoimmunization. Am J Obstet Gynecol 1: 152:341-344.
139. Nicolaides KH, Campbell S, Gabbe SG, Guidetti R. 1986. Ultrasound screening for spina bifida: Cranial and cerebellar signs. Lancet 2:72-74.
140. Nicolaides KH, Soothill PW, Clewell WH, rodeck CH, Mibashan R, Campbell S. 1988. Fetal haemoglobin measurement in the assessment of red cell isoimmunisation. Lancet 1:1073-1075.
141. Nicolaides KH, Azar G, Byrne D, Mansur C, Marks K. 1992a. Fetal nuchal translucency: Ultrasound screening for chromosomal defects in first trimester of pregnancy. Br Med J 304:867-889.
142. Nicolaides KH, Azar G, Snijders RJM, Gosden CM. 1992b. Fetal nuchal edema: Associated malformations and chromosomal defects. Fetal Diagn Ther 7:123-131.
143. Nicolaides KH, Sebire NJ, Snijders JM. 1996. Crown rump length in chromosomally abnormal fetuses. In: Nicolaides KH, editor. The 11-14-week scan-The diagnosis of fetal abnormalities. New York: Parthenon Publishing. p 31-33.
144. Nicolaides KH, Spencer K, Avgidou K, Faiola S, Falcon O. 2005. Multicenter study of first-trimester screening for trisomy 21 in 75 821 pregnancies: Results and estimation of the potential impact of individual risk-orientated two-stage first-trimester screening. Ultrasound Obstet Gynecol 25:221-226.
145. Noble PL, Snijders RJM, Abraha HD, Sherwood RA, Nicolaides KH. 1997. Maternal serum free beta-hCG at 10 to 14 weeks in trisomic twin pregnancies. Br J Obstet Gynaecol 104:741-743.
146. Orlandi F, Bilardo CM, Campogrande M, Krants D, Hallahan T, Rossi C, Viora E. 2003. Measurement of nasal bone length at 11-14 weeks of pregnancy and its potential role in Down's syndrome risk assessment. Ultrasound Obstet Gynecol 22:36-39.
147. Orvos H, Wayda K, Kozinsky Z, Katona M, Pál A, Szabó J. 2002. Increased nuchal translucency and congenital heart defects in euploid fetuses. The Szeged experience. Eur J Obstet Gynecol Reprod Biol 101: 124-128.
148. Otano L, Aiello H, Igarzabal L, Matayoshi T, Gadow EC. 2002. Association between first trimester absence of fetal nasal bone on ultrasound and Downs syndrome. Prenat Diagn 22:930-932.
149. Pachi A, Giancotti A, Torcia F, de Prosperi V, Maggi E. 1989. Meckel-Gruber syndrome: Ultrasonographic diagnosis at 13 weeks' gestational age in an at-risk case. Prenatal Diag 9:187-190.
150. Pajkrt E, van Lith JMM, Mol BWJ, Bleker OP, Bilardo CM. 1998. Screening for Down's syndrome by fetal nuchal translucency measurement in a general obstetric population. Ultrasound Obstet Gynecol 12:163-169.
151. Pandya PP, Kondylios A, Hilbert L, Snijders RJM, Nicolaides KH. 1995. Chromosomal defects and outcome in 1015 fetuses with increased nuchal translucency. Ultrasound Obstet Gynecol 5:15-19.
152. Pannier E, Viot G, Aubry MC, Grange G, Tantau J, Fallet-Bianco C, Muller F, Cabrol D. 2003. Congenital erythropoietic porphyria (Gunthers disease): Two cases with very early prenatal manifestation and cystic hydroma. Prenat Diagn 23:25-30.
153. Percin EF, Guvenal T, Cetin A, Percin S, Goze F Arici S. 2001. First-trimester diagnosis of Robinow syndrome. Fetal Diagn Ther 16: 308-311.
154. Petrikovsky BM, Baker D, Schneider E. 1996. Fetal hydrops secondary to human parvovirus infection in early pregnancy. Prenat Diagn 16:342-344.
155. Petrikovsky BM, Gross B, Bialer M, Solamanzadeh K, Simhaee E. 1997. Prenatal diagnosis of pseudothalidomide syndrome in consecutive pregnancies of a consanguineous couple. Ultrasound Obstet Gynecol 10: 425-428.
156. Rembouskos G, Cicero S, Longo D, Sacchini C, Nicolaides KH. 2003. Single Umbilical Artery at 11-14 weeks: Relation to chromosomal defects. Ultrasound Obstet Gynecol 22:567-570.
157. Reynders CS, Pauker SP, Benacerraf BR. 1997. First trimester isolated fetal nuchal lucency: Significance and outcome. J Ultrasound Med 16:101-105.
158. Rijhsinghani A, Yankowitz J, Howser D, Williamson R. 1997. Sonographic and maternal serum screening abnormalities in fetuses affected by spinal muscular atrophy. Prenat Diagn 17:166-169.
159. Rizzo G, Muscatello A, Angelini E, Capponi A. 2003. Abnormal cardiac function in fetuses with increased nuchal translucency Ultrasound Obstet Gynecol 21:539-542.
160. Rodriguez-Niedenfuhr M, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Tomarev SI, Wilting J. 2001. Prox1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts. Anat Embryol 204:399-406.
161. Rosati P, Guariglia L. 1996. Transvaginal sonographic assessment of the fetal urinary tract in early pregnancy. Ultrasound Obstet Gynecol 7:95-100.
162. Rottem S, Bronshtein M, Thaler I, Brandes JM. 1989. First trimester transvaginal sonographic diagnosis of fetal anomalies. Lancet 1:444-445.
163. Sacchini C, El-Sheikhah A, Cicero S, Rembouskos G, Nicolaides KH. 2003. Ear length in trisomy 21 fetuses at 11-14 weeks of gestation. Ultrasound Obstet Gynecol 22:460-463.
164. Salvesen DR, Goble O. 1995. Early amniocentesis and fetal nuchal translucency in women requesting karyotyping for advanced maternal age. Prenat Diagn 15:971-974.
165. Sandikcioglu M, Moisted K, Kjaer I. 1994. The prenatal development of the human nasal and vomeral bones. J Craniofac Genet Dev Biol 14:124-134.
166. Schemm S, Gembruch U, Germer U, Janig U, Jonat W, von Kaisenberg CS. 2003. Omphalocele-exstrophy-imperforate anus-spinal defects (OEIS) complex associated with increased nuchal translucency. Ultrasound Obstet Gynecol 22:95-97.
167. Schemmer G, Wapner RJ, Johnson A, Schemmer M, Norton HJ, Anderson WE. 1997. First-trimester growth patterns of aneuploid fetuses. Prenat Diagn 17:155-159.
168. Schmidt W, Kubli F. 1982. Early diagnosis of severe congenital malformations by ultrasonography. J Perinat Med 10:233-241.
169. Schwarzler P, Carvalho JS, Senat MV Masroor T, Campbell S, Ville Y. 1999. Screening for fetal aneuploidies and fetal cardiac abnormalities by nuchal translucency thickness measurement at 10-14 weeks of gestation as part of routine antenatal care in an unselected population. Br J Obstet Gynaecol 106:1029-1034.
170. Sebire NJ, Von Kaisenberg C, Rubio C, Nicolaides KH. 1996. Fetal megacystis at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 8:387-390.
171. Sebire NJ, Bianco D, Snijders RJM, Zuckerman M, Nicolaides KH. 1997. Increased fetal nuchal translucency thickness at 10-14 weeks: Is screening for maternal-fetal infection necessary? Br J Obstet Gynaecol 104:212-215.
172. Sebire NJ, Noble PL, Thorpe-Beeston JG, Snijders RJM, Nicolaides KH. 1997a. Presence of the "lemon" sign in fetuses with spina bifida at the 10-14 week scan. Ultrasound Obstet Gynecol 10:403-405.
173. Sebire NJ, Snijders RJM, Davenport M, Greenough A, Nicolaides KH. 1997b. Fetal nuchal translucency thickness at 10-14 weeks of gestation and congenital diaphragmatic hernia. Obstet Gynecol 90:943-947.
174. Senat MV, De Keersmaecker B, Audibert F Montcharmont G, Frydman R, Ville Y. 2002. Pregnancy outcome in fetuses with increased nuchal translucency and normal karyotype. Prenat Diagn 22:345-349.
175. Sepulveda W, Sebire NJ, Hughes K, Odibo A, Nicolaides KH. 1996. The lambda sign at 10-14 weeks of gestation as a predictor of chorionicity in twin pregnancies. Ultrasound Obstet Gynecol 7:421-423.
176. Sepulveda W, Sebire NJ, Souka A, Snijders RJM, Nicolaides KH. 1997. Diagnosis of Meckel-Gruber syndrome at eleven to fourteen weeks' gestation. Am J Obstet Gynecol 176:316-319.
177. Sharp P, Haant E, Fletcher JM, Khong TY, Carey WF. 1997. First-trimester diagnosis of Smith-Lemli-Opitz syndrome. Prenat Diagn 17:355-361.
178. Sherrod C, Sebire NJ, Soares W, Snijders RJ, Nicolaides KH. 1997. Prenatal diagnosis of trisomy 18 at the 10-14-week ultrasound scan. Ultrasound Obstet Gynecol 10:387-390.
179. Shulman LP, Emerson DS, Grevengood C, Felker RE, Gross SJ, Phillips OP, Elias S. 1994. Clinical course and outcome of fetuses with isolated cystic nuchal lesions and normal karyotypes detected in the first trimester. Am J Obstet Gynecol 171:1278-1281.
180. Simpson JM, Sharland GK. 2000. Nuchal translucency and congenital heart defects: Heart failure or not? Ultrasound Obstet Gynecol 16:30-36.
181. Simpson JM, Jones A, Callaghan N, Sharland GK. 2000. Accuracy and limitations of transabdominal fetal echocardiography at 12-15 weeks of gestation in a population at high risk for congenital heart disease. Br J Obstet Gynecol 107:1492-1497.
182. Smrcek JM, Gembruch U, Krokowski M, Berg C, Krapp M, Geipel A, Germer U. 2003a. The evaluation of cardiac biometry in major cardiac defects detected in early pregnancy. Arch Gynecol Obstet 268:94-101.
183. Smrcek JM, Germer U, Krokowski M, Berg C, Krapp M, Geipel A, Gembruch U. 2003b. Prenatal ultrasound diagnosis and management of body stalk anomaly: Analysis of nine singleton and two multiple pregnancies. Ultrasound Obstet Gynecol 21:322-328.
184. Smulian JC, Egan JF, Rodis JF. 1998. Fetal hydrops in the first trimester associated with maternal parvovirus infection. J Clin Ultrasound 26:314-316.
185. Snijders RJ, Sebire NJ, Souka A, Santiago C, Nicolaides KH. 1995. Fetal exomphalos and chromosomal defects: Relationship to maternal age and gestation. Ultrasound Obstet Gynecol 6:250-255.
186. Snijders RJM, Farrias M, von Kaisenberg C, Nicolaides KH. 1996. Fetal abnormalities. In: Snijders RJM, Nicolaides KH, editors. Ultrasound markers for fetal chromosomal defects. Carnforth, UK: Parthenon Publishing. p 1-62.
187. Snijders RJM, Noble P, Sebire N, Souka A, Nicolaides KH. 1998. UK multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal translucency thickness at 10-14 weeks of gestation. Lancet 351:343-346.
188. Snijders RJ, Sebire NJ, Nayar R, Souka A, Nicolaides KH. 1999. Increased nuchal translucency in trisomy 13 fetuses at 10-14 weeks of gestation. Am J Med Genet 86:205-207.
189. Sohan K, Carroll S, Byrne D, Ashworth M, Soothill P. 2000. Parvovirus as a differential diagnosis of hydrops fetalis in the first trimester. Fetal Diagn Ther 15:234-236.
190. Sonek J, Nicolaides K. 2002. Prenatal ultrasonographic diagnosis of nasal bone abnormalities in three fetuses with Down syndrome. Am J Obstet Gynecol 186:139-141.
191. Sonek J, Cicero S, Neiger R, Nicolaides K. 2006a. Nasal bone assessment in prenatal screening for trisomy 21. Am J Obstet Gynecol 195:1219-1230.
192. Sonek J, Croom C, McKenna D, Neiger R. 2006b. Letter to the Editor. Obstet Gynecol 107:424.
193. Sonek JD, Borenstein M, Dagklis T, Persico N, Nicolaides KH. 2006c. Pronto maxillary facial angles in fetuses with trisomy 21 at 11-13+6 weeks of gestation. Am J Obstet Gynecol (in press).
194. Soothill PW, Vuthiwong C, Rees H. 1993. Achondrogenesis type 2 diagnosed by transvaginal ultrasound at 12 weeks of gestation. Prenat Diagn 13:523-528.
195. Sonka AP, Snidjers RJM, Novakov A, Soares W, Nicolaides KH. 1998. Defects and syndromes in chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks of gestation. Ultrasound Obstet Gynecol 11:391-400.
196. Souka AP, Krampl E, Bakalis S, Heath V, Nicolaides KH. 2001. Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 18:9-17.
197. Souka AP, Bower S, Geerts L, Huggon I, Nicolaides KH. 2002a. Blackfan-Diamond anemia and dyserythropoietic anemia presenting with increased nuchal translucency at 12 weeks of gestation. Ultrasound Obstet Gynecol 20:197-199.
198. Souka AP, Krampl E, Geerts L, Nicolaides KH. 2002b. Congenital lymphedema presenting with increased nuchal translucency at 13 weeks of gestation. Prenat Diagn 22:91-92.
199. Souka AP, Raymond FL, Mornet E, Geerts L, Rane S, Nicolaides KH. 2002c. Hypophosphatasia associated with increased nuchal translucency: A report of three consecutive pregnancies. Ultrasound Obstet Gynecol 20:294-295.
200. Souka AP, Skentou H, Geerts L, Bower S, Nicolaides KH. 2002d. Congenital nephrotic syndrome presenting with increased nuchal translucency in the first trimester. Prenat Diagn 22:93-95.
201. Souka AP, Pilalis A, Kavalakis I, Antsaklis P, Papantoniou N, Mesogitis S, Antsaklis A. 2006. Screening for major structural abnormalities at the 11- to 14-week ultrasound scan. Am J Obstet Gynecol 194:393-396.
202. Souter V, Nyberg D, Siebert JR, Gonzales A, Luthardt F, Hannibal M, Glass I. 2002. Upper limb phocomelia associated with increased nuchal translucency in a monochorionic twin pregnancy. J Ultrasound Med 21:355-360.
203. Spencer K. 2000. Screening for trisomy 21 in twin pregnancies in the first trimester using free beta-hCG and PAPP-A, combined with fetal nuchal translucency thickness. Prenat Diagn 20:91-95.
204. Spencer K, Nicolaides KH. 2003. Screening for trisomy 21 in twins using first trimester ultrasound and maternal serum biochemistry in a one-stop clinic: A review of three years experience. Br J Obstet Gynaecol 110:276-280.
205. Spencer K, Souter V, Tul N, Snijders R, Nicolaides KH. 1999. A screening program for trisomy 21 at 10-14 weeks using fetal nuchal translucency, maternal serum free β-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound Obstet Gynecol 13:231-237.
206. Stempfle N, Huten Y, Fredouille C, Brisse H, Nessmann C. 1999. Skeletal abnormalities in fetuses with Down's syndrome: A radiologic postmortem study. Pediatr Radiol. 29:682-688.
207. Stiller RJ, Lieberson D, Herzlinger R, Siddiqui D, Laifer SA, Whetham JCG. 1999. The association of increased fetal nuchal translucency and spinal muscular atrophy type 1. Prenat Diagn 19:587-589.
208. Tercanli S, Miny P, Siebert MS, Hosli I, Surbek DV, Holzgreve W. 2001. Fanconi anemia associated with increased nuchal translucency detected by first-trimester ultrasound. Ultrasound Obstet Gynecol 17:160-162.
209. Trauftcr ML, Anderson CE, Johnson A, Heeger S, Morgan P, Wapner RJ. 1994. The natural history of euploid pregnancies with first-trimester cystic hygromas. Am J Obstet Gynecol 170:1279-1284.
210. Tsuchimochi H, Kurimoto F, Leki K, Koyama H, Takaku F, Kawana M, Kimata S, Yazaki Y. 1988. Atrial natriuretic peptide distribution in fetal and failed adult human hearts. Circulation 78:920-927.
211. Tuxen A, Keeling JW, Reintoft I, Fischer Hansen B, Nolting D, Kjaer I. 2003. A histological and radiological investigation of the nasal bone in fetuses with Down syndrome. Ultrasound Obstet Gynecol 22:22-26.
212. Ulm B, Ulm MR, Deutinger J, Bernaschek G. 1997. Dandy-Walker malformation diagnosed before 21 weeks of gestation: Associated malformations and chromosomal abnormalities. Ultrasound Obstet Gynecol 10:167-170.
213. van der Putte SCJ, van Limborogh J. 1980. The embryonic development of the main lymphatics in man. Acta Morphol Neerl-Scand 8:323-335.
214. Van Vugt JM, Tinnemans BW, Van Zalen-Sprock RM. 1998. Outcome and early childhood follow-up of chromosomally normal fetuses with increased nuchal translucency at 10-14 weeks' gestation. Ultrasound Obstet Gynecol 11:407-409.
215. van Zalen-Sprock M, Van Vugt JMG, van der Harten HJ, van Geijn HP. 1992a. Cephalocele and cystic hygroma: Diagnosis and differentiation in the first trimester of pregnancy with transvaginal sonography: Report of two cases. Utrasound Obstet Gynecol 2:289-292.
216. van Zalen-Sprock RM, van VugtJMG, van Geijn HP. 1992b. First-trimester diagnosis of cystic hygroma-Course and outcome. Am J Obstet Gynecol 167:94-98.
217. van Zalen-Sprock RM, van Vugt JMG, van Geijn HP. 1997. First-trimester sonography of physiological midgut herniation and early diagnosis of omphalocele. Prenat Diagn 17:511-518.
218. Varlet F, Bousquet F, Clemenson A, Chauleur C, Kopp-Dutour N, Tronchet M, Teyssier G, Prieur F, Varlet MN. 2003. Congenital diaphragmatic hernia. Two cases with early prenatal diagnosis and increased nuchal translucency. Fetal Diagn Ther 18:33-35.
219. Ville Y, Lalondrelle C, Doumerc S, Daffos F, Frydman R, Oury JF, Dumez Y. 1992. First-trimester diagnosis of nuchal anomalies: Significance and fetal outcome. Ultrasound Obstet Gynecol 2:314-316.
220. Viora E, Masturzo B, Errante G, Sciarrone A, Bastonero S, Campogrande M. 2003a. Ultrasound evaluation of fetal nasal bone at 11 to 14 weeks in a consecutive series of 1906 fetuses. Prenat Diagn 23:784-787.
221. Viora E, Sciarrone A, Bastonero S, Errante G, Botta G, Franceschini PG, Campogrande M. 2003b. Osteogenesis imperfecta associated with increased nuchal translucency as a first ultrasound sign: Report of another case. Ultrasound Obstet Gynecol 21:200-202.
222. von Kaisenberg CS, Huggon I, Hyett JA, Farzaneh F, Nicolaides KH. 1997. Cardiac expression of sarcoplasmic reticulum calcium ATPase in fetuses with trisomy 21 and trisomy 18 presenting with nuchal translucency Fetal Diagn Ther 12:270-273.
223. von Kaisenberg CS, Brand-Saberi B, Christ B, Vallian S, Farzaneh F, Nicolaides KH. 1998a. Collagen type VI gene expression in the skin of trisomy 21 fetuses. Obstet Gynecol 91: 319-323.
224. von Kaisenberg CS, Krenn V, Ludwig M, Nicolaides KH, Brand-Saberi B. 1998b. Morphological classification of nuchal skin in fetuses with trisomy 21, 18 and 13 at 12-18 weeks and in a trisomy 16 mouse. Anat Embryol 197:105-124.
225. Warkany J. 1971. Anencephaly. In: Warkany J, editor. Congenital malformations. Chicago: Yearbook Publishers. p 189-200.
226. Welch KK, Malone FD. 2003. Nuchal translucency-based screening. Clinical Obstet Gynecol 46:909-922.
227. Whitlow BJ, Economides DL. 1998. The optimal gestational age to examine fetal anatomy and measure nuchal translucency in the first trimester. Ultrasound Obstet Gynecol 11: 258-261.
228. Wong SF, Choi H, Ho LC. 2003. Nasal bone hypoplasia: Is it a common finding amongst chromosomally normal fetuses of southern Chinese women? Gynecol Obstet Invest 56:99-101.
229. Zoppi MA, Putzolu M, Ibba RM, Floris M, Monni G. 2002. First-trimester ductus venosus velocimetry in relation to nuchal translucency thickness and fetal karyotype. Fetal Diagn Ther 17:52-57.
230. Zoppi MA, Ibba RM, Axinan C, Floris M, Manca F, Monni G. 2003. Absence of fetal nasal bone and aneuploidies at first-trimester nuchal translucency screening in unselected pregnancies. Prenat Diagn 23: 496-500.
231. Zosmer N, Souter VL, Chan CSY, Huggon IC, Nicolaides KH. 1999. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. Br J Obstet Gynaecol 106:829-833.